(KNTK) Kinetik Holdings - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US02215L2097
Stock: Natural Gas, Liquids, Oil, Water
Total Rating 42
Risk 33
Buy Signal -0.35
| Risk 5d forecast | |
|---|---|
| Volatility | 37.5% |
| Relative Tail Risk | -1.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -26.11 |
| Character TTM | |
|---|---|
| Beta | 1.057 |
| Beta Downside | 1.245 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.98% |
| CAGR/Max DD | 0.46 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 113.1951
Description: KNTK Kinetik Holdings March 05, 2026
Kinetik Holdings Inc. (KNTK) is a midstream energy company operating in the Texas Delaware Basin.
The company provides essential infrastructure and services to upstream oil and gas producers. Its operations are divided into two segments: Midstream Logistics and Pipeline Transportation. Midstream companies primarily focus on the transportation, processing, and storage of oil, natural gas, and natural gas liquids (NGLs).
Kinetiks services include gathering, compression, processing, stabilization, treating, storage, and pipeline transportation. They also offer water gathering and disposal, a critical service for hydraulic fracturing operations. The company generates revenue by selling condensates, natural gas residue, and NGLs.
For more detailed financial and operational insights, consider exploring ValueRay.
Headlines to watch out for
- Natural gas and crude oil prices impact midstream service demand
- Regulatory changes to pipeline infrastructure affect profitability
- Delaware Basin drilling activity drives gathering and processing volumes
- Interest rate fluctuations influence capital expenditure for expansion
- NGL and condensate sales contribute to revenue volatility
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 252.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 88.79 > 0.02 and ΔFCF/TA 8874 > 1.0 |
| NWC/Revenue: -9.14% < 20% (prev -8.35%; Δ -0.79% < -1%) |
| CFO/TA 152.9 > 3% & CFO 604.1m > Net Income 252.4m |
| Net Debt (3.98b) to EBITDA (1.19b): 3.35 < 3 |
| Current Ratio: 0.02 > 1.5 & < 3 |
| Outstanding Shares: last quarter (64.6m) vs 12m ago 6.71% < -2% |
| Gross Margin: 31.58% > 18% (prev 0.36%; Δ 3121 % > 0.5%) |
| Asset Turnover: 51.75% > 50% (prev 21.76%; Δ 29.99% > 0%) |
| Interest Coverage Ratio: 3.51 > 6 (EBITDA TTM 1.19b / Interest Expense TTM 229.4m) |
Altman Z'' -15.00
| A: -40.81 (Total Current Assets 3.95m - Total Current Liabilities 165.2m) / Total Assets 3.95m |
| B: -204.0 (Retained Earnings -806.1m / Total Assets 3.95m) |
| C: 0.24 (EBIT TTM 806.0m / Avg Total Assets 3.41b) |
| D: -0.20 (Book Value of Equity -806.1m / Total Liabilities 3.98b) |
| Altman-Z'' Score: -931.5 = D |
Beneish M -4.00
| DSRI: 0.64 (Receivables 85.3m/111.9m, Revenue 1.76b/1.48b) |
| GMI: 1.15 (GM 31.58% / 36.29%) |
| AQI: -2222 (AQ_t -996.6 / AQ_t-1 0.45) |
| SGI: 1.19 (Revenue 1.76b / 1.48b) |
| TATA: -89.01 (NI 252.4m - CFO 604.1m) / TA 3.95m) |
| Beneish M-Score: -1413 (Cap -4..+1) = AAA |
What is the price of KNTK shares?
As of March 09, 2026, the stock is trading at USD 45.58 with a total of 974,305 shares traded.
Over the past week, the price has changed by -2.86%, over one month by +7.88%, over three months by +25.89% and over the past year by -0.67%.
Over the past week, the price has changed by -2.86%, over one month by +7.88%, over three months by +25.89% and over the past year by -0.67%.
Is KNTK a buy, sell or hold?
Kinetik Holdings has received a consensus analysts rating of 3.71.
Therefor, it is recommend to hold KNTK.
- StrongBuy: 3
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the KNTK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.7 | 2.4% |
| Analysts Target Price | 46.7 | 2.4% |
KNTK Fundamental Data Overview March 05, 2026
P/E Trailing = 113.1951
P/E Forward = 21.8818
P/S = 1.6842
P/B = 1.3294
P/EG = 8.6228
Revenue TTM = 1.76b USD
EBIT TTM = 806.0m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 3.96b USD (from longTermDebt, two quarters ago)
Short Term Debt = 165.2m USD (from shortTermDebt, last quarter)
Debt = 3.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.98b USD (from netDebt column, last quarter)
Enterprise Value = 6.95b USD (2.97b + Debt 3.98b - CCE 3.95m)
Interest Coverage Ratio = 3.51 (Ebit TTM 806.0m / Interest Expense TTM 229.4m)
EV/FCF = 19.81x (Enterprise Value 6.95b / FCF TTM 350.8m)
FCF Yield = 5.05% (FCF TTM 350.8m / Enterprise Value 6.95b)
FCF Margin = 19.88% (FCF TTM 350.8m / Revenue TTM 1.76b)
Net Margin = 14.31% (Net Income TTM 252.4m / Revenue TTM 1.76b)
Gross Margin = 31.58% ((Revenue TTM 1.76b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 22.19% (prev 34.08%)
Tobins Q-Ratio = 1759 (set to none) (Enterprise Value 6.95b / Total Assets 3.95m)
Interest Expense / Debt = 1.49% (Interest Expense 59.4m / Debt 3.98b)
Taxrate = 8.70% (39.7m / 456.4m)
NOPAT = 735.9m (EBIT 806.0m * (1 - 8.70%))
Current Ratio = 0.02 (Total Current Assets 3.95m / Total Current Liabilities 165.2m)
Debt / Equity = -1.00 (negative equity) (Debt 3.98b / totalStockholderEquity, last quarter -3.98b)
Debt / EBITDA = 3.35 (Net Debt 3.98b / EBITDA 1.19b)
Debt / FCF = 11.34 (Net Debt 3.98b / FCF TTM 350.8m)
Total Stockholder Equity = -2.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.40% (Net Income 252.4m / Total Assets 3.95m)
RoE = -10.23% (negative equity) (Net Income TTM 252.4m / Total Stockholder Equity -2.47b)
RoCE = 54.14% (EBIT 806.0m / Capital Employed (Equity -2.47b + L.T.Debt 3.96b))
RoIC = 37.50% (NOPAT 735.9m / Invested Capital 1.96b)
WACC = 4.97% (E(2.97b)/V(6.95b) * Re(9.81%) + D(3.98b)/V(6.95b) * Rd(1.49%) * (1-Tc(0.09)))
Discount Rate = 9.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.53%
[DCF] Terminal Value 87.10% ; FCFF base≈355.1m ; Y1≈385.1m ; Y5≈479.6m
[DCF] Fair Price = 159.3 (EV 14.18b - Net Debt 3.98b = Equity 10.20b / Shares 64.0m; r=5.90% [WACC]; 5y FCF grow 9.60% → 2.90% )
EPS Correlation: 19.37 | EPS CAGR: 43.33% | SUE: 3.63 | # QB: 1
Revenue Correlation: 90.42 | Revenue CAGR: 14.71% | SUE: -1.88 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.26 | Chg7d=-0.072 | Chg30d=-0.072 | Revisions Net=-2 | Analysts=1
EPS current Year (2026-12-31): EPS=1.51 | Chg7d=-0.107 | Chg30d=-0.107 | Revisions Net=-2 | Growth EPS=-51.2% | Growth Revenue=+21.7%
EPS next Year (2027-12-31): EPS=2.24 | Chg7d=-0.171 | Chg30d=-0.171 | Revisions Net=-3 | Growth EPS=+48.3% | Growth Revenue=+9.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.9% (Discount Rate 9.8% - Earnings Yield 0.9%)
[Growth] Growth Spread = -14.0% (Analyst -5.1% - Implied 8.9%)
P/E Forward = 21.8818
P/S = 1.6842
P/B = 1.3294
P/EG = 8.6228
Revenue TTM = 1.76b USD
EBIT TTM = 806.0m USD
EBITDA TTM = 1.19b USD
Long Term Debt = 3.96b USD (from longTermDebt, two quarters ago)
Short Term Debt = 165.2m USD (from shortTermDebt, last quarter)
Debt = 3.98b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.98b USD (from netDebt column, last quarter)
Enterprise Value = 6.95b USD (2.97b + Debt 3.98b - CCE 3.95m)
Interest Coverage Ratio = 3.51 (Ebit TTM 806.0m / Interest Expense TTM 229.4m)
EV/FCF = 19.81x (Enterprise Value 6.95b / FCF TTM 350.8m)
FCF Yield = 5.05% (FCF TTM 350.8m / Enterprise Value 6.95b)
FCF Margin = 19.88% (FCF TTM 350.8m / Revenue TTM 1.76b)
Net Margin = 14.31% (Net Income TTM 252.4m / Revenue TTM 1.76b)
Gross Margin = 31.58% ((Revenue TTM 1.76b - Cost of Revenue TTM 1.21b) / Revenue TTM)
Gross Margin QoQ = 22.19% (prev 34.08%)
Tobins Q-Ratio = 1759 (set to none) (Enterprise Value 6.95b / Total Assets 3.95m)
Interest Expense / Debt = 1.49% (Interest Expense 59.4m / Debt 3.98b)
Taxrate = 8.70% (39.7m / 456.4m)
NOPAT = 735.9m (EBIT 806.0m * (1 - 8.70%))
Current Ratio = 0.02 (Total Current Assets 3.95m / Total Current Liabilities 165.2m)
Debt / Equity = -1.00 (negative equity) (Debt 3.98b / totalStockholderEquity, last quarter -3.98b)
Debt / EBITDA = 3.35 (Net Debt 3.98b / EBITDA 1.19b)
Debt / FCF = 11.34 (Net Debt 3.98b / FCF TTM 350.8m)
Total Stockholder Equity = -2.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.40% (Net Income 252.4m / Total Assets 3.95m)
RoE = -10.23% (negative equity) (Net Income TTM 252.4m / Total Stockholder Equity -2.47b)
RoCE = 54.14% (EBIT 806.0m / Capital Employed (Equity -2.47b + L.T.Debt 3.96b))
RoIC = 37.50% (NOPAT 735.9m / Invested Capital 1.96b)
WACC = 4.97% (E(2.97b)/V(6.95b) * Re(9.81%) + D(3.98b)/V(6.95b) * Rd(1.49%) * (1-Tc(0.09)))
Discount Rate = 9.81% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 7.53%
[DCF] Terminal Value 87.10% ; FCFF base≈355.1m ; Y1≈385.1m ; Y5≈479.6m
[DCF] Fair Price = 159.3 (EV 14.18b - Net Debt 3.98b = Equity 10.20b / Shares 64.0m; r=5.90% [WACC]; 5y FCF grow 9.60% → 2.90% )
EPS Correlation: 19.37 | EPS CAGR: 43.33% | SUE: 3.63 | # QB: 1
Revenue Correlation: 90.42 | Revenue CAGR: 14.71% | SUE: -1.88 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.26 | Chg7d=-0.072 | Chg30d=-0.072 | Revisions Net=-2 | Analysts=1
EPS current Year (2026-12-31): EPS=1.51 | Chg7d=-0.107 | Chg30d=-0.107 | Revisions Net=-2 | Growth EPS=-51.2% | Growth Revenue=+21.7%
EPS next Year (2027-12-31): EPS=2.24 | Chg7d=-0.171 | Chg30d=-0.171 | Revisions Net=-3 | Growth EPS=+48.3% | Growth Revenue=+9.6%
[Analyst] Revisions Ratio: -1.00 (0 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.9% (Discount Rate 9.8% - Earnings Yield 0.9%)
[Growth] Growth Spread = -14.0% (Analyst -5.1% - Implied 8.9%)